<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Fractional excretion of sodium, urea, and other molecules in acute kidney injury</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Fractional excretion of sodium, urea, and other molecules in acute kidney injury</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Fractional excretion of sodium, urea, and other molecules in acute kidney injury</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Mark D Okusa, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Tushar A Chopra, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Paul M Palevsky, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Eric N Taylor, MD, MSc, FASN</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 15, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The fractional excretion of sodium (FENa) measures the percent of filtered sodium that is excreted in the urine. This calculation is widely used to help differentiate prerenal disease (decreased kidney perfusion) from acute tubular necrosis (ATN) as the cause of acute kidney injury (AKI, formerly called acute renal failure). (See  <a class="medical medical_review" href="/z/d/html/7216.html" rel="external">"Etiology and diagnosis of prerenal disease and acute tubular necrosis in acute kidney injury in adults", section on 'Evaluation and diagnosis'</a>.)</p><p>As described below, there are a number of <strong>limitations to the use of FENa</strong> in patients with AKI. These limitations include the small sample size of studies supporting the use of FENa, the variability of the threshold FENa that is used to define prerenal disease, the presence of multiple causes of a low FENa other than prerenal disease, and errors associated with the use of measures of sodium excretion in the setting of renal salt wasting (as with diuretic therapy). Thus, the etiology of AKI should be based upon the <strong>totality of the presentation</strong> (history, clinical examination, urine microscopy, and, when appropriate, response to volume resuscitation), not just on the FENa. FENa could play a supportive role in the diagnosis of hepatorenal syndrome, a disorder that is characterized by oliguria, avid sodium reabsorption, urine Na &lt;10 mEq/L, and FENa &lt;1 percent [<a href="#rid1">1</a>]. When diuretics may still be active and the FENa is not low, the fractional excretion of urea (FEUrea) may be helpful. (See <a class="local">'Limitations of fractional excretion of sodium'</a> below and <a class="local">'Urea'</a> below.)</p><p>Although not yet in widespread clinical use, novel urinary and serum biomarkers to assess intrinsic tubular injury are being evaluated [<a href="#rid2">2-5</a>]. (See  <a class="medical medical_review" href="/z/d/html/7216.html" rel="external">"Etiology and diagnosis of prerenal disease and acute tubular necrosis in acute kidney injury in adults", section on 'Evaluation and diagnosis'</a>.)</p><p class="headingAnchor" id="H132096866"><span class="h2">Formula</span><span class="headingEndMark"> — </span>The filtered sodium load can be determined from the product of the glomerular filtration rate (GFR; as estimated from the creatinine clearance) and the serum sodium concentration (SNa). On the other hand, urinary sodium excretion is equal to the product of the urine sodium concentration (UNa) and the urine flow rate (V). Thus:</p><div class="formulaContainer"><div class="formula"><p>                                                    quantity of Na<sup>+</sup> excreted<br/>          FENa, percent    =      ——————————————————    x    100<br/>                                                      quantity of Na<sup>+</sup> filtered</p></div></div><div class="formulaContainer"><div class="formula"><p>                                                          UNa   x   V<br/>          FENa, percent    =      ——————————————————    x    100<br/>                                            SNa   x   [(UCr  x  V)  ÷  SCr]</p></div></div><p>where urine creatinine concentration (UCr) and serum creatinine concentration (SCr) are the urine and serum creatinine concentrations, respectively. This equation can be simplified since the urine flow rate terms (V) cancel out, allowing the FENa to be estimated from simultaneously obtained serum and urine specimens without measuring the urine volume [<a href="#rid6">6</a>]:</p><div class="formulaContainer"><div class="formula"><p>                                           UNa   x   SCr<br/>          FENa, percent    =       ———————    x    100<br/>                                           SNa   x   UCr<br/></p></div></div><p>Calculators for the FENa are available using either standard units (<a class="calc calc_professional" href="/z/d/html/13497.html" rel="external">calculator 1</a>) or SI units (<a class="calc calc_professional" href="/z/d/html/13499.html" rel="external">calculator 2</a>).</p><p class="headingAnchor" id="H2"><span class="h1">OVERVIEW</span><span class="headingEndMark"> — </span>The FENa is commonly used to assist in differentiating prerenal disease (a transient reduction in glomerular filtration rate [GFR] due solely to decreased kidney perfusion) from acute tubular necrosis (ATN), the two most common causes of AKI [<a href="#rid6">6-9</a>]. However, there is some overlap since severe prerenal disease, particularly if accompanied by hypotension, is also a common cause of ATN. In addition to the laboratory tests, a careful history and physical examination are essential [<a href="#rid9">9</a>]. (See  <a class="medical medical_review" href="/z/d/html/7216.html" rel="external">"Etiology and diagnosis of prerenal disease and acute tubular necrosis in acute kidney injury in adults", section on 'Causes of acute tubular necrosis'</a>.)</p><p>The FEUrea and other molecules, such as <a class="drug drug_general" data-topicid="9566" href="/z/d/drug information/9566.html" rel="external">lithium</a> and uric acid, have also been evaluated for their utility in the distinction between prerenal disease and ATN [<a href="#rid9">9,10</a>]. The FEUrea may be particularly helpful in patients who are being treated with diuretics, which can transiently raise the FENa above the value used to diagnose prerenal disease. (See <a class="local">'Fractional excretion of other molecules'</a> below.)</p><p class="headingAnchor" id="H3"><span class="h1">FRACTIONAL EXCRETION OF SODIUM IN ACUTE KIDNEY INJURY</span><span class="headingEndMark"> — </span>The FENa may be useful in patients suspected of having AKI due to either prerenal disease or acute tubular necrosis (ATN). A variety of studies have confirmed that the FENa more clearly differentiates between these two conditions than other laboratory tests [<a href="#rid7">7,8,11,12</a>]. The urine sodium concentration, the urine-to-serum creatinine ratio, and the urine osmolality all have a much lower predictive value. However, FENa does not have enough accuracy to be used as a sole diagnostic test for this purpose [<a href="#rid13">13</a>]. (See <a class="local">'Fractional excretion of sodium versus urine sodium concentration'</a> below and  <a class="medical medical_review" href="/z/d/html/7216.html" rel="external">"Etiology and diagnosis of prerenal disease and acute tubular necrosis in acute kidney injury in adults", section on 'Other tests that may be helpful'</a>.)</p><p>The clinical value of calculating the FENa is highest in patients with oliguric AKI who do not have preexisting chronic kidney disease (CKD) and who are not taking diuretics. In patients with CKD and/or those taking diuretics, the FENa may often be high (ie, above 2 percent) even in the setting of hypovolemia. As an example, in a systematic review of 15 studies and 827 patients with AKI, the sensitivity and specificity of a FENa less than 1 percent to correctly identify prerenal disease were 90 percent (95% CI 81-95 percent) and 82 percent (95% CI 70-90 percent), respectively [<a href="#rid14">14</a>]. Among those patients with oliguria and no preexisting CKD or use of diuretics, the sensitivity and specificity were higher (95 and 91 percent, respectively). By contrast, sensitivity and specificity were lower among those with CKD or diuretic use (83 and 66 percent, respectively).</p><p>In general, a FENa below 1 percent suggests prerenal disease, where the reabsorption of almost all of the filtered sodium represents an appropriate response to decreased renal perfusion. In comparison, a value between 1 and 2 percent may be seen with either disorder, while a value above 2 percent usually indicates ATN. However, a FENa below 1 percent is not diagnostic of prerenal disease, since it can be seen in a variety of other causes of AKI. (See <a class="local">'Multiple causes of acute kidney injury with FENa less than 1 percent'</a> below and  <a class="medical medical_review" href="/z/d/html/7216.html" rel="external">"Etiology and diagnosis of prerenal disease and acute tubular necrosis in acute kidney injury in adults", section on 'Fractional excretion of sodium and urine sodium concentration'</a>.)</p><p>The above cut-off values <strong>apply only in patients with advanced AKI</strong>. The FENa values that define prerenal disease are lower in patients with less severe disease since the filtered sodium load is much higher, being as low as 0.1 percent in patients with normal kidney function. Another potential problem is that the glomerular filtration rate (GFR) cannot be estimated from a single serum creatinine measurement, since the serum creatinine is not stable. (See <a class="local">'Fractional excretion of sodium varies with glomerular filtration rate'</a> below and <a class="local">'Single measurements of serum creatinine may be misleading'</a> below.)</p><p>The relatively high FENa in ATN can be due to one or both of the following factors: inappropriate sodium wasting due to tubular damage and/or an appropriate response of the remaining, well-preserved nephrons to volume expansion. Inappropriate sodium wasting is most likely to be important early in the disease, when nephrons that are still filtering have impaired tubular function. In comparison, volume expansion may be more important in patients with established ATN and normal tissue perfusion. At this time, most of the damaged nephrons may be nonfunctioning, with the urine output primarily coming from a relatively small number of well-preserved nephrons. In this setting, the maintenance of sodium balance requires a high FENa.</p><p>As an example, suppose a patient with established ATN has a GFR that has fallen from the normal level of 180 L/day (125 mL/min) down to 20 L/day. If the plasma water sodium concentration is 150 mEq/L, then the filtered sodium load will be 3000 mEq/day (20 x 150). If sodium intake is 75 mEq/day, then excretion of the ingested sodium will require a FENa of 2.5 percent (75 ÷ 3000).</p><p class="headingAnchor" id="H4"><span class="h2">Fractional excretion of sodium versus urine sodium concentration</span><span class="headingEndMark"> — </span>The FENa is generally more accurate than the urine sodium concentration in differentiating prerenal disease from ATN because it directly measures sodium handling. In contrast, the urine sodium concentration is also affected by the rate of water reabsorption. As an example, a patient who is both water and sodium avid due to prerenal disease may, because of the low urine volume, have a relatively high urine sodium concentration of 20 to 40 mEq/L or more, despite having little sodium in the urine.</p><p class="headingAnchor" id="H5"><span class="h2">Limitations of fractional excretion of sodium</span><span class="headingEndMark"> — </span>There are important limitations to the use of FENa in establishing the cause of AKI  (<a class="graphic graphic_table graphicRef128102" href="/z/d/graphic/128102.html" rel="external">table 1</a>) [<a href="#rid9">9</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>The FENa criterion of less than 1 percent to diagnose prerenal disease applies <strong>only</strong> to patients with a marked reduction in GFR. (See <a class="local">'Fractional excretion of sodium varies with glomerular filtration rate'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Single measurements of serum creatinine may not provide an accurate estimate of the GFR. (See <a class="local">'Single measurements of serum creatinine may be misleading'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>There are a number of causes of AKI other than prerenal disease in which the FENa can be less than 1 percent. (See <a class="local">'Multiple causes of acute kidney injury with FENa less than 1 percent'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The FENa may be above 1 percent when prerenal disease occurs in patients with chronic kidney disease or any cause of sodium wasting, such as diuretic therapy while the diuretic is still acting. (See <a class="local">'Prerenal disease in patients with chronic kidney disease'</a> below and <a class="local">'Diuretic therapy'</a> below.)</p><p></p><p class="headingAnchor" id="H713876789"><span class="h3">Fractional excretion of sodium varies with glomerular filtration rate</span><span class="headingEndMark"> — </span>As mentioned above, the FENa is more reliable in patients with AKI than the urine sodium concentration since it does not vary with the urine volume. However, the FENa value of 1 percent that distinguishes prerenal disease from ATN applies only in patients with a <strong>marked reduction in GFR</strong>. In patients with less severe disease, the GFR and therefore the filtered sodium load are higher, and, at the same level of urinary sodium excretion, the FENa will be lower. Thus, there is <strong>no absolute FENa value that is always diagnostic of prerenal disease</strong>, which emphasizes the importance of using FENa in relation to the clinical context.</p><p>If, for example, the filtered sodium load is very low at 3000 mEq/day (GFR 20 L/day, which is approximately 14 mL/min [normal 180 L/day or 125 mL/min], and the plasma water sodium concentration is 150 mEq/L), then a FENa below 1 percent is required to appropriately reduce sodium excretion below 20 mEq/day, if prerenal disease were the only problem.</p><p>The results are quite different when the GFR is normal or only modestly reduced. At a normal GFR of 180 L/day and plasma water sodium concentration of 150 mEq/L, the filtered sodium load is 27,000 mEq/day. A FENa of 1 percent in this setting represents the excretion of 270 mEq/day, which is greater than the average sodium intake of 80 to 250 mEq/day. Thus, almost all individuals with a normal GFR have a FENa below 1 percent. To reduce sodium excretion to less than 20 mEq/day in the presence of volume depletion requires a FENa below 0.1 percent. This value increases to 0.2 percent if the GFR is 50 percent of normal, 0.4 percent if the GFR is 25 percent of normal, and 1 percent if the GFR is 10 percent of normal.</p><p>These examples illustrate the difficulty of using the FENa to diagnose prerenal disease in settings other than severe AKI.</p><p class="headingAnchor" id="H791015361"><span class="h3">Single measurements of serum creatinine may be misleading</span><span class="headingEndMark"> — </span>The GFR <strong>cannot</strong> be estimated from a single serum creatinine measurement, since the serum creatinine is not stable. </p><p>Suppose, for example, that a patient with septic shock is admitted to the hospital. The patient may be oliguric and have little or no kidney function. However, if the disease duration is only a few hours, the serum creatinine will still be close to the patient's baseline value since there has not been time for creatinine to be retained. Thus, a serum creatinine of 1 mg/dL (88 micromol/L) could be present in a patient with a normal baseline GFR who now has little or no glomerular filtration. The presence of AKI will be apparent from serial measurements of the serum creatinine, which can initially rise by as much as 2 mg/dL (177 micromol/L) or more per day.</p><p>The same principle applies to patients with underlying chronic kidney disease. A patient with a baseline serum creatinine of 2.5 mg/dL (221 micromol/L) may initially have the same value shortly after the onset of severe AKI even though the GFR is markedly reduced. (See <a class="local">'Prerenal disease in patients with chronic kidney disease'</a> below.)</p><p class="headingAnchor" id="H194655831"><span class="h3">Multiple causes of acute kidney injury with FENa less than 1 percent</span><span class="headingEndMark"> — </span>The history, physical examination, and urinary findings are important in evaluating patients with AKI because the FENa can be less than 1 percent in patients with a variety of conditions other than prerenal disease [<a href="#rid6">6-8,15,16</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span>Some patients with postischemic ATN who have less severe disease and are evaluated early in the course, as they are making the transition from prerenal disease to postischemic ATN, or remain ischemic with established ATN [<a href="#rid15">15</a>]. In the latter setting, most of the urine output may be coming from a small number of more normal nephrons. A low FENa is appropriate in these nephrons due to the continued kidney ischemia and can be achieved since tubular function is relatively intact. The injured nephrons do not prevent sodium conservation, since they are largely nonfunctioning.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>ATN superimposed upon a chronic prerenal disease, such as cirrhosis or heart failure, due to the mechanism described in the preceding bullet [<a href="#rid17">17</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Approximately 10 percent of patients with nonoliguric ATN, presumably due to persistent kidney ischemia and less severe disease [<a href="#rid15">15</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Some patients with ATN associated with (early) sepsis [<a href="#rid12">12,18</a>] and in animal models of septic AKI [<a href="#rid19">19,20</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>AKI due to radiocontrast media or heme pigments (myoglobinuria or hemoglobinuria) [<a href="#rid21">21,22</a>]. (See  <a class="medical medical_review" href="/z/d/html/14034.html" rel="external">"Clinical features and diagnosis of heme pigment-induced acute kidney injury", section on 'Urinalysis'</a> and  <a class="medical medical_review" href="/z/d/html/7241.html" rel="external">"Contrast-associated and contrast-induced acute kidney injury: Clinical features, diagnosis, and management", section on 'Clinical features'</a>.)</p><p></p><p>Thus, a FENa less than 1 percent may be present in many patients with ATN; conversely, the presence of "muddy brown" granular casts appear to be a stronger predictor of ATN than FENa. As an example, in one cohort study of 270 patients with AKI, the accuracies of the FENa and the muddy brown granular casts in the urine sediment were evaluated for the prediction of a final diagnosis of ATN (which was confirmed by kidney biopsy in a subset) [<a href="#rid23">23</a>]. ATN was the final diagnosis in 186 patients; 115 had abundant muddy brown granular casts in the urine sediment. The presence of abundant muddy brown granular casts in the urine had a positive predictive value of 100 percent for a final diagnosis ATN. However, 33 percent of those with abundant muddy brown granular casts also had a FENa less than 1 percent. The low FENa with muddy brown granular casts could be due to varied responses across nephron segments; some nephron segments are sodium avid while others are necrotic; particularly the distal portion of the proximal tubule, the S3 segment of the outer medulla, and the thick ascending limb of the loop of Henle are susceptible to injury during hypoperfusion. (See  <a class="medical medical_review" href="/z/d/html/7216.html" rel="external">"Etiology and diagnosis of prerenal disease and acute tubular necrosis in acute kidney injury in adults"</a>.)</p><p>In addition to ATN, a FENa less than 1 percent can be seen in other causes of AKI:</p><p class="bulletIndent1"><span class="glyph">●</span>Acute glomerulonephritis or vasculitis in which the diagnosis is typically suspected from the active urine sediment (red cells with or without red cell casts) and variable degrees of proteinuria [<a href="#rid11">11,16</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Some cases of acute interstitial nephritis, particularly if nonoliguric and if the kidney failure is less severe [<a href="#rid24">24,25</a>]. The diagnosis may be suspected from the history (eg, exposure to a drug known to cause interstitial nephritis) and from laboratory findings such as eosinophilia and, in the urine sediment, white cells with or without white cell casts and, in many cases, eosinophiluria [<a href="#rid16">16</a>]. (See  <a class="medical medical_review" href="/z/d/html/7234.html" rel="external">"Clinical manifestations and diagnosis of acute interstitial nephritis", section on 'Laboratory and radiographic findings'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Acute urinary tract obstruction (rare).</p><p></p><p>In each of the last four conditions, it is presumed that the low FENa reflects well-preserved tubular function in the face of a reduction in GFR [<a href="#rid8">8</a>].</p><p class="headingAnchor" id="H1441649657"><span class="h3">Prerenal disease in patients with chronic kidney disease</span><span class="headingEndMark"> — </span>In patients with chronic kidney disease, sodium conservation in response to any acute cause of prerenal disease or an abrupt decrease in dietary sodium intake is often impaired [<a href="#rid26">26-28</a>]. As a result, the FENa may initially be greater than 1 percent.</p><p>One or more of the following three factors may contribute to the inability to conserve sodium in patients with chronic kidney disease [<a href="#rid26">26-28</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>The osmotic diuresis induced by increased urea excretion per nephron due to the decreased number of functioning nephrons</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Tubular injury due to the underlying disease</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Probably most important, an inability to acutely shut off natriuretic forces</p><p></p><p>Support for the last mechanism was provided by a study of patients with chronic kidney disease and apparent salt wasting (with acute obligatory losses as high as 300 mEq/day) [<a href="#rid28">28</a>]. All of the patients were able to maintain sodium balance at a sodium intake of only 5 mEq/day when intake was gradually reduced over a period of weeks, rather than acutely.</p><p class="headingAnchor" id="H10326913"><span class="h3">Diuretic therapy</span><span class="headingEndMark"> — </span>A FENa greater than 1 percent can occur in patients with prerenal disease who are treated with diuretics if the measurement is made while the diuretic is still acting. In such patients, the fractional excretion of urea (FEUrea) may be helpful, and the FENa can be measured again after the diuretic effect has worn off. (See <a class="local">'Urea'</a> below.)</p><p class="headingAnchor" id="H7"><span class="h1">FRACTIONAL EXCRETION OF OTHER MOLECULES</span><span class="headingEndMark"> — </span>Values for the FENa and urine sodium concentration that are not low are difficult to interpret when there is concurrent use of diuretics, which are commonly used in patients with AKI. The ensuing natriuresis will raise the FENa, even in patients with prerenal disease. In older patients, the natriuresis may be delayed following diuretic administration. This was illustrated in a study of patients given a single dose of <a class="drug drug_general" data-topicid="8482" href="/z/d/drug information/8482.html" rel="external">furosemide</a> (1 mg/kg) [<a href="#rid29">29</a>]. The peak FENa was achieved at 30 minutes following injection in younger patients (17 to 40 years old) and at 120 minutes following injection in older patients (75 to 80 years old). Thus, timing of the urine sample can lead to variability in the measurement of FENa, rendering this test less reliable after diuretic use.</p><p>Because of this variability, the clinical utility of the FEUrea, <a class="drug drug_general" data-topicid="9566" href="/z/d/drug information/9566.html" rel="external">lithium</a>, and uric acid have been studied since these substances are primarily reabsorbed and, with uric acid, secreted in the proximal tubule, which is proximal to the sites of action of loop diuretics (loop of Henle) or thiazide diuretics (distal tubule). Of these, the FEUrea may be most useful in patients being treated with diuretics, although inconsistent results have been reported.</p><p>The accuracy of all of the proximal markers requires <strong>intact proximal function</strong>. As an example, the fractional excretion of these markers will increase, independent of volume status, when proximal reabsorption is reduced, as occurs during a glucose osmotic diuresis in uncontrolled diabetes mellitus [<a href="#rid30">30</a>].</p><p class="headingAnchor" id="H194656238"><span class="h2">Urea</span><span class="headingEndMark"> — </span>The measurement of the FEUrea may be useful in patients with AKI. FEUrea is generally 50 to 65 percent in acute tubular necrosis (ATN) and below 35 percent in prerenal disease [<a href="#rid30">30-36</a>], and the effect of diuretics on the FEUrea is less than the effect on FENa [<a href="#rid36">36</a>]. Some [<a href="#rid30">30,33</a>], but not all [<a href="#rid31">31</a>] prospective studies have shown that FEUrea is superior to FENa for distinguishing between prerenal and intrinsic disease among patients on diuretics. However, FENa retains superior accuracy for discriminating between prerenal and intrinsic disease in patients not on diuretics [<a href="#rid31">31,33</a>] and in those for whom the diuretic effect has worn off. </p><p class="headingAnchor" id="H9"><span class="h2">Lithium</span><span class="headingEndMark"> — </span>Endogenous <a class="drug drug_general" data-topicid="9566" href="/z/d/drug information/9566.html" rel="external">lithium</a> is present in the circulation in trace amounts. In the kidney, filtered lithium is primarily reabsorbed in the proximal tubule. Thus, proximal reabsorption of lithium is increased in prerenal disease, which will lower lithium excretion. This proximal tubular reabsorption of lithium is not influenced by loop diuretics or by thiazide diuretics other than those such as <a class="drug drug_general" data-topicid="9248" href="/z/d/drug information/9248.html" rel="external">chlorothiazide</a> that also act in the proximal tubule because they inhibit carbonic anhydrase [<a href="#rid37">37</a>].</p><p>The fractional excretion of <a class="drug drug_general" data-topicid="9566" href="/z/d/drug information/9566.html" rel="external">lithium</a> (FELi) is approximately 20 percent in healthy controls. The potential utility of the FELi was illustrated in a study of 46 patients with AKI (prerenal disease in 26 and ATN in 18) [<a href="#rid38">38</a>]. A FELi below 15 percent (and usually below 10 percent) was highly suggestive of prerenal disease, independent of diuretic therapy. In comparison, the mean FELi was 26 percent in ATN. A FELi below 15 percent or above 25 percent had a sensitivity of 93 to 96 percent but a much lower specificity of 56 to 72 percent. The sensitivity was higher than seen with the FENa (75 percent) in patients treated with diuretic therapy. The clinical utility of the FELi<sub> </sub>is limited by the lack of widespread availability of trace lithium measurements.</p><p class="headingAnchor" id="H10"><span class="h2">Uric acid</span><span class="headingEndMark"> — </span>Uric acid is another marker that is almost entirely handled in the proximal tubule. As a result, the fractional excretion of uric acid is not affected by loop or thiazide diuretics.</p><p>In the study of 46 patients with AKI cited in the preceding section, a fractional excretion of uric acid below 12 percent was suggestive of prerenal disease (sensitivity 68 percent [much lower than the sensitivity of the FELi in the same study], specificity 78 percent), while values above 20 percent were highly suggestive of ATN, although the specificity was low (sensitivity 96 percent, specificity 33 percent) [<a href="#rid38">38</a>].</p><p class="headingAnchor" id="H496609766"><span class="h1">INVESTIGATIONAL BIOMARKERS</span><span class="headingEndMark"> — </span>Although not yet in widespread clinical use, novel urinary and serum biomarkers are being evaluated for the possible early detection of acute tubular necrosis (ATN) that might permit therapy that would minimize the degree of AKI. (See  <a class="medical medical_review" href="/z/d/html/85837.html" rel="external">"Investigational biomarkers and the evaluation of acute kidney injury"</a>.)</p><p class="headingAnchor" id="H11"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Formula for the fractional excretion of sodium (FENa)</strong> – The FENa measures the percent of filtered sodium that is excreted in the urine. In the following formula, UNa and UCr represent concentrations of urine sodium and creatinine, respectively, and SNa and SCr represent concentrations of serum sodium and creatinine, respectively. Calculators for the FENa are available using either standard units (<a class="calc calc_professional" href="/z/d/html/13497.html" rel="external">calculator 1</a>) or SI units (<a class="calc calc_professional" href="/z/d/html/13499.html" rel="external">calculator 2</a>). (See <a class="local">'Formula'</a> above.)</p><p></p><div class="formulaContainer"><div class="formula"><p>                                           UNa   x   SCr<br/>          FENa, percent    =       ———————    x    100<br/>                                           SNa   x   UCr</p></div></div><p class="bulletIndent1"><span class="glyph">●</span><strong>Overview</strong> – The FENa is commonly used to assist in differentiating prerenal disease (a reduction in glomerular filtration rate [GFR] due solely to decreased kidney perfusion) from acute tubular necrosis (ATN), the two most common causes of acute kidney injury (AKI). (See <a class="local">'Overview'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>FENa values and AKI</strong> – Among patients with suspected prerenal disease or ATN, we typically measure the FENa. A value of the FENa below 1 percent commonly indicates prerenal disease; in comparison, a value between 1 and 2 percent may be seen with either disorder, while a value above 2 percent usually indicates ATN. (See <a class="local">'Fractional excretion of sodium in acute kidney injury'</a> above and  <a class="medical medical_review" href="/z/d/html/7216.html" rel="external">"Etiology and diagnosis of prerenal disease and acute tubular necrosis in acute kidney injury in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Limitations of FENa and use of fractional excretion of urea</strong> <strong>(FEUrea)</strong> – There are a number of limitations to use of the FENa in patients with AKI:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The FENa defining prerenal disease varies with the GFR, ranging from less than 0.1 percent in patients with normal kidney function to more than 1 percent in AKI. (See <a class="local">'Fractional excretion of sodium varies with glomerular filtration rate'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Single measurements of the serum creatinine are not a good measure of GFR, since the serum creatinine is not stable in early AKI. (See <a class="local">'Single measurements of serum creatinine may be misleading'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In addition to prerenal disease, the FENa can be less than 1 percent in patients who have postischemic ATN, ATN superimposed upon a chronic prerenal disease, nonoliguric ATN, AKI due to radiocontrast media or heme pigments, acute glomerulonephritis or vasculitis, acute interstitial nephritis, or (rarely) acute urinary tract obstruction. (See <a class="local">'Multiple causes of acute kidney injury with FENa less than 1 percent'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The FENa may initially be greater than 1 percent when prerenal disease occurs in patients with underlying chronic kidney disease. (See <a class="local">'Prerenal disease in patients with chronic kidney disease'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The FENa and the urine sodium concentration may be difficult to interpret with concurrent diuretic therapy. In this setting, measuring the FEUrea may be helpful. (See <a class="local">'Diuretic therapy'</a> above and <a class="local">'Urea'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Fractional excretion of other molecules</strong> – The fractional excretion of <a class="drug drug_general" data-topicid="9566" href="/z/d/drug information/9566.html" rel="external">lithium</a> (FELi) and uric acid are not commonly measured, since data are more limited than with FENa and FEUrea. Other biomarkers of AKI are being evaluated. (See <a class="local">'Fractional excretion of other molecules'</a> above.)</p><p></p><p class="headingAnchor" id="H3263319130"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Rasheed Balogun, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Arroyo V, Ginès P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 1996; 23:164.</a></li><li><a class="nounderline abstract_t">Koyner JL, Vaidya VS, Bennett MR, et al. Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clin J Am Soc Nephrol 2010; 5:2154.</a></li><li><a class="nounderline abstract_t">Westhoff JH, Fichtner A, Waldherr S, et al. Urinary biomarkers for the differentiation of prerenal and intrinsic pediatric acute kidney injury. Pediatr Nephrol 2016; 31:2353.</a></li><li><a class="nounderline abstract_t">Nejat M, Pickering JW, Devarajan P, et al. Some biomarkers of acute kidney injury are increased in pre-renal acute injury. Kidney Int 2012; 81:1254.</a></li><li><a class="nounderline abstract_t">Malhotra R, Katz R, Jotwani V, et al. Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD. Clin J Am Soc Nephrol 2020; 15:349.</a></li><li class="breakAll">Rose BD. Pathophysiology of Renal Disease, 2nd ed, McGraw-Hill, New York City 1987. p.68.</li><li><a class="nounderline abstract_t">Steiner RW. Interpreting the fractional excretion of sodium. Am J Med 1984; 77:699.</a></li><li><a class="nounderline abstract_t">Miller TR, Anderson RJ, Linas SL, et al. Urinary diagnostic indices in acute renal failure: a prospective study. Ann Intern Med 1978; 89:47.</a></li><li><a class="nounderline abstract_t">Perazella MA, Coca SG. Traditional urinary biomarkers in the assessment of hospital-acquired AKI. Clin J Am Soc Nephrol 2012; 7:167.</a></li><li><a class="nounderline abstract_t">Kanbay M, Kasapoglu B, Perazella MA. Acute tubular necrosis and pre-renal acute kidney injury: utility of urine microscopy in their evaluation- a systematic review. Int Urol Nephrol 2010; 42:425.</a></li><li><a class="nounderline abstract_t">Espinel CH, Gregory AW. Differential diagnosis of acute renal failure. Clin Nephrol 1980; 13:73.</a></li><li><a class="nounderline abstract_t">Vanmassenhove J, Glorieux G, Hoste E, et al. Urinary output and fractional excretion of sodium and urea as indicators of transient versus intrinsic acute kidney injury during early sepsis. Crit Care 2013; 17:R234.</a></li><li><a class="nounderline abstract_t">Pons B, Lautrette A, Oziel J, et al. Diagnostic accuracy of early urinary index changes in differentiating transient from persistent acute kidney injury in critically ill patients: multicenter cohort study. Crit Care 2013; 17:R56.</a></li><li><a class="nounderline abstract_t">Abdelhafez M, Nayfeh T, Atieh A, et al. Diagnostic Performance of Fractional Excretion of Sodium for the Differential Diagnosis of Acute Kidney Injury: A Systematic Review and Meta-Analysis. Clin J Am Soc Nephrol 2022; 17:785.</a></li><li><a class="nounderline abstract_t">Brosius FC, Lau K. Low fractional excretion of sodium in acute renal failure: role of timing of the test and ischemia. Am J Nephrol 1986; 6:450.</a></li><li><a class="nounderline abstract_t">Zarich S, Fang LS, Diamond JR. Fractional excretion of sodium. Exceptions to its diagnostic value. Arch Intern Med 1985; 145:108.</a></li><li><a class="nounderline abstract_t">Diamond JR, Yoburn DC. Nonoliguric acute renal failure associated with a low fractional excretion of sodium. Ann Intern Med 1982; 96:597.</a></li><li><a class="nounderline abstract_t">Bagshaw SM, Haase M, Haase-Fielitz A, et al. A prospective evaluation of urine microscopy in septic and non-septic acute kidney injury. Nephrol Dial Transplant 2012; 27:582.</a></li><li><a class="nounderline abstract_t">Bagshaw SM, Langenberg C, Wan L, et al. A systematic review of urinary findings in experimental septic acute renal failure. Crit Care Med 2007; 35:1592.</a></li><li><a class="nounderline abstract_t">Langenberg C, Wan L, Bagshaw SM, et al. Urinary biochemistry in experimental septic acute renal failure. Nephrol Dial Transplant 2006; 21:3389.</a></li><li><a class="nounderline abstract_t">Fang LS, Sirota RA, Ebert TH, Lichtenstein NS. Low fractional excretion of sodium with contrast media-induced acute renal failure. Arch Intern Med 1980; 140:531.</a></li><li><a class="nounderline abstract_t">Corwin HL, Schreiber MJ, Fang LS. Low fractional excretion of sodium. Occurrence with hemoglobinuric- and myoglobinuric-induced acute renal failure. Arch Intern Med 1984; 144:981.</a></li><li><a class="nounderline abstract_t">Varghese V, Rivera MS, Alalwan A, et al. Concomitant Identification of Muddy Brown Granular Casts and Low Fractional Excretion of Urinary Sodium in AKI. Kidney360 2022; 3:627.</a></li><li><a class="nounderline abstract_t">Saha H, Mustonen J, Helin H, Pasternack A. Limited value of the fractional excretion of sodium test in the diagnosis of acute renal failure. Nephrol Dial Transplant 1987; 2:79.</a></li><li><a class="nounderline abstract_t">Lins RL, Verpooten GA, De Clerck DS, De Broe ME. Urinary indices in acute interstitial nephritis. Clin Nephrol 1986; 26:131.</a></li><li><a class="nounderline abstract_t">Coleman AJ, Arias M, Carter NW, et al. The mechanism of salt wastage in chronic renal disease. J Clin Invest 1966; 45:1116.</a></li><li><a class="nounderline abstract_t">Yeh BP, Tomko DJ, Stacy WK, et al. Factors influencing sodium and water excretion in uremic man. Kidney Int 1975; 7:103.</a></li><li><a class="nounderline abstract_t">Danovitch GM, Bourgoignie J, Bricker NS. Reversibility of the "salt-losing" tendency of chronic renal failure. N Engl J Med 1977; 296:14.</a></li><li><a class="nounderline abstract_t">Kaplan AA, Kohn OF. Fractional excretion of urea as a guide to renal dysfunction. Am J Nephrol 1992; 12:49.</a></li><li><a class="nounderline abstract_t">Carvounis CP, Nisar S, Guro-Razuman S. Significance of the fractional excretion of urea in the differential diagnosis of acute renal failure. Kidney Int 2002; 62:2223.</a></li><li><a class="nounderline abstract_t">Pépin MN, Bouchard J, Legault L, Ethier J. Diagnostic performance of fractional excretion of urea and fractional excretion of sodium in the evaluations of patients with acute kidney injury with or without diuretic treatment. Am J Kidney Dis 2007; 50:566.</a></li><li><a class="nounderline abstract_t">Diskin CJ, Stokes TJ, Dansby LM, et al. Toward the optimal clinical use of the fraction excretion of solutes in oliguric azotemia. Ren Fail 2010; 32:1245.</a></li><li><a class="nounderline abstract_t">Diskin CJ, Stokes TJ, Dansby LM, et al. The comparative benefits of the fractional excretion of urea and sodium in various azotemic oliguric states. Nephron Clin Pract 2010; 114:c145.</a></li><li><a class="nounderline abstract_t">Schönermarck U, Kehl K, Samtleben W. Diagnostic performance of fractional excretion of urea and sodium in acute kidney injury. Am J Kidney Dis 2008; 51:870.</a></li><li><a class="nounderline abstract_t">Wlodzimirow KA, Abu-Hanna A, Royakkers AA, et al. Transient versus persistent acute kidney injury and the diagnostic performance of fractional excretion of urea in critically ill patients. Nephron Clin Pract 2014; 126:8.</a></li><li><a class="nounderline abstract_t">Cox ZL, Sury K, Rao VS, et al. Effect of Loop Diuretics on the Fractional Excretion of Urea in Decompensated Heart Failure. J Card Fail 2020; 26:402.</a></li><li><a class="nounderline abstract_t">Boer WH, Koomans HA, Dorhout Mees EJ. Acute effects of thiazides, with and without carbonic anhydrase inhibiting activity, on lithium and free water clearance in man. Clin Sci (Lond) 1989; 76:539.</a></li><li><a class="nounderline abstract_t">Steinhäuslin F, Burnier M, Magnin JL, et al. Fractional excretion of trace lithium and uric acid in acute renal failure. J Am Soc Nephrol 1994; 4:1429.</a></li></ol></div><div id="topicVersionRevision">Topic 7219 Version 30.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8550036" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20798258" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27286687" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Urinary biomarkers for the differentiation of prerenal and intrinsic pediatric acute kidney injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22418979" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Some biomarkers of acute kidney injury are increased in pre-renal acute injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32111704" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32111704" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6486145" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Interpreting the fractional excretion of sodium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/666184" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Urinary diagnostic indices in acute renal failure: a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22096038" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Traditional urinary biomarkers in the assessment of hospital-acquired AKI.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19921458" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Acute tubular necrosis and pre-renal acute kidney injury: utility of urine microscopy in their evaluation- a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7363517" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Differential diagnosis of acute renal failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24119730" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Urinary output and fractional excretion of sodium and urea as indicators of transient versus intrinsic acute kidney injury during early sepsis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23531299" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Diagnostic accuracy of early urinary index changes in differentiating transient from persistent acute kidney injury in critically ill patients: multicenter cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35545442" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Diagnostic Performance of Fractional Excretion of Sodium for the Differential Diagnosis of Acute Kidney Injury: A Systematic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3565502" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Low fractional excretion of sodium in acute renal failure: role of timing of the test and ischemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3970621" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Fractional excretion of sodium. Exceptions to its diagnostic value.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7073153" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Nonoliguric acute renal failure associated with a low fractional excretion of sodium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21669886" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : A prospective evaluation of urine microscopy in septic and non-septic acute kidney injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17452939" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : A systematic review of urinary findings in experimental septic acute renal failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16998215" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Urinary biochemistry in experimental septic acute renal failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7362385" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Low fractional excretion of sodium with contrast media-induced acute renal failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6712414" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Low fractional excretion of sodium. Occurrence with hemoglobinuric- and myoglobinuric-induced acute renal failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35721603" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Concomitant Identification of Muddy Brown Granular Casts and Low Fractional Excretion of Urinary Sodium in AKI.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3112654" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Limited value of the fractional excretion of sodium test in the diagnosis of acute renal failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3769228" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Urinary indices in acute interstitial nephritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16695913" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : The mechanism of salt wastage in chronic renal disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1113451" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Factors influencing sodium and water excretion in uremic man.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/618364" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Reversibility of the "salt-losing" tendency of chronic renal failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1415365" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Fractional excretion of urea as a guide to renal dysfunction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12427149" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Significance of the fractional excretion of urea in the differential diagnosis of acute renal failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17900456" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Diagnostic performance of fractional excretion of urea and fractional excretion of sodium in the evaluations of patients with acute kidney injury with or without diuretic treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20954990" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Toward the optimal clinical use of the fraction excretion of solutes in oliguric azotemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19887835" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : The comparative benefits of the fractional excretion of urea and sodium in various azotemic oliguric states.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18436107" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Diagnostic performance of fractional excretion of urea and sodium in acute kidney injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24434683" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Transient versus persistent acute kidney injury and the diagnostic performance of fractional excretion of urea in critically ill patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32007554" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Effect of Loop Diuretics on the Fractional Excretion of Urea in Decompensated Heart Failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2721120" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Acute effects of thiazides, with and without carbonic anhydrase inhibiting activity, on lithium and free water clearance in man.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8161725" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Fractional excretion of trace lithium and uric acid in acute renal failure.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
